<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36876049</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-889X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in molecular biosciences</Title><ISOAbbreviation>Front Mol Biosci</ISOAbbreviation></Journal><ArticleTitle>Metabolomics as a powerful tool for diagnostic, pronostic and drug intervention analysis in COVID-19.</ArticleTitle><Pagination><StartPage>1111482</StartPage><MedlinePgn>1111482</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1111482</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmolb.2023.1111482</ELocationID><Abstract><AbstractText>COVID-19 currently represents one of the major health challenges worldwide. Albeit its infectious character, with onset affectation mainly at the respiratory track, it is clear that the pathophysiology of COVID-19 has a systemic character, ultimately affecting many organs. This feature enables the possibility of investigating SARS-CoV-2 infection using multi-omic techniques, including metabolomic studies by chromatography coupled to mass spectrometry or by nuclear magnetic resonance (NMR) spectroscopy. Here we review the extensive literature on metabolomics in COVID-19, that unraveled many aspects of the disease including: a characteristic metabotipic signature associated to COVID-19, discrimination of patients according to severity, effect of drugs and vaccination treatments and the characterization of the natural history of the metabolic evolution associated to the disease, from the infection onset to full recovery or long-term and long sequelae of COVID.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Bruzzone, Conde, Embade, Mato and Millet.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bruzzone</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bilbao, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conde</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bilbao, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Embade</LastName><ForeName>Nieves</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bilbao, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mato</LastName><ForeName>Jos&#xe9; M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bilbao, Bizkaia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Millet</LastName><ForeName>Oscar</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Basque Research and Technology Alliance (BRTA), Bilbao, Bizkaia, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBERehd, Instituto de Salud Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Mol Biosci</MedlineTA><NlmUniqueID>101653173</NlmUniqueID><ISSNLinking>2296-889X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">LC/GC-MS</Keyword><Keyword MajorTopicYN="N">NMR</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 infection</Keyword><Keyword MajorTopicYN="N">lipidomics</Keyword><Keyword MajorTopicYN="N">long covid</Keyword><Keyword MajorTopicYN="N">metabolomics</Keyword><Keyword MajorTopicYN="N">phenoreversion</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>6</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36876049</ArticleId><ArticleId IdType="pmc">PMC9975567</ArticleId><ArticleId IdType="doi">10.3389/fmolb.2023.1111482</ArticleId><ArticleId IdType="pii">1111482</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alb&#xf3;niga O. E., Jim&#xe9;nez D., S&#xe1;nchez-Conde M., Vizcarra P., Ron R., Herrera S., et al. (2022). Metabolic snapshot of plasma samples reveals new pathways implicated in SARS-CoV-2 pathogenesis. J. Proteome Res. 21, 623&#x2013;634. 10.1021/acs.jproteome.1c00786</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00786</ArticleId><ArticleId IdType="pubmed">35133846</ArticleId></ArticleIdList></Reference><Reference><Citation>Alzahrani F. A., Mohammed M. R. S., Alkarim S., Azhar E. I., El-Magd M. A., Hawsawi Y., et al. (2021). Untargeted metabolic profiling of extracellular vesicles of sars-cov-2-infected patients shows presence of potent anti-inflammatory metabolites. Int. J. Mol. Sci. 22, 10467. 10.3390/ijms221910467</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910467</ArticleId><ArticleId IdType="pmc">PMC8509011</ArticleId><ArticleId IdType="pubmed">34638812</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashraf U. M., Abokor A. A., Edwards J. M., Waigi E. W., Royfman R. S., Hasan S. A. M., et al. (2021). Sars-cov-2, ace2 expression, and systemic organ invasion. Physiol. Genomics 53, 51&#x2013;60. 10.1152/physiolgenomics.00087.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physiolgenomics.00087.2020</ArticleId><ArticleId IdType="pmc">PMC7900915</ArticleId><ArticleId IdType="pubmed">33275540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai Y., Huang W., Li Y., Lai C., Huang S., Wang G., et al. (2021). Lipidomic alteration of plasma in cured COVID-19 patients using ultra high-performance liquid chromatography with high-resolution mass spectrometry. Biosci. Rep. 41, BSR20204305&#x2013;12. 10.1042/BSR20204305</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20204305</ArticleId><ArticleId IdType="pmc">PMC7937909</ArticleId><ArticleId IdType="pubmed">33635316</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E., Amede E., Khoso S., Castello L., Sainaghi P. P., Bellan M., et al. (2021a). Metabolomics diagnosis of Covid-19 from exhaled breath condensate. Metabolites 11, 847. 10.3390/metabo11120847</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11120847</ArticleId><ArticleId IdType="pmc">PMC8708149</ArticleId><ArticleId IdType="pubmed">34940605</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E., Amede E., Tavecchia M., Marengo E., Cittone M. G., Rizzi E., et al. (2021b). Understanding protection from SARS-CoV-2 using metabolomics. Sci. Rep. 11, 13796&#x2013;13810. 10.1038/s41598-021-93260-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93260-2</ArticleId><ArticleId IdType="pmc">PMC8257707</ArticleId><ArticleId IdType="pubmed">34226622</ArticleId></ArticleIdList></Reference><Reference><Citation>Barberis E., Timo S., Amede E., Vanella V. V., Puricelli C., Cappellano G., et al. (2020). Large-scale plasma analysis revealed new mechanisms and molecules associated with the host response to sars-cov-2. Int. J. Mol. Sci. 21, 8623&#x2013;8625. 10.3390/ijms21228623</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21228623</ArticleId><ArticleId IdType="pmc">PMC7696386</ArticleId><ArticleId IdType="pubmed">33207699</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennet S., Kaufmann M., Takami K., Sjaarda C., Douchant K., Moslinger E., et al. (2022). Small-molecule metabolome identifies potential therapeutic targets against COVID-19. Sci. Rep. 12, 10029&#x2013;10111. 10.1038/s41598-022-14050-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14050-y</ArticleId><ArticleId IdType="pmc">PMC9200216</ArticleId><ArticleId IdType="pubmed">35705626</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi X., Liu W., Ding X., Liang S., Zheng Y., Zhu X., et al. (2022). Proteomic and metabolomic profiling of urine uncovers immune responses in patients with COVID-19. Cell Rep. 38, 110271. 10.1016/j.celrep.2021.110271</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.110271</ArticleId><ArticleId IdType="pmc">PMC8712267</ArticleId><ArticleId IdType="pubmed">35026155</ArticleId></ArticleIdList></Reference><Reference><Citation>Bingol K. (2018). Recent advances in targeted and untargeted metabolomics by NMR and MS/NMR methods. High. Throughput 7, 9. 10.3390/ht7020009</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ht7020009</ArticleId><ArticleId IdType="pmc">PMC6023270</ArticleId><ArticleId IdType="pubmed">29670016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bissonnette L., Bergeron M. G. (2012). Infectious disease management through point-of-care personalized medicine molecular diagnostic technologies. J. Pers. Med. 2, 50&#x2013;70. 10.3390/jpm2020050</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm2020050</ArticleId><ArticleId IdType="pmc">PMC4251365</ArticleId><ArticleId IdType="pubmed">25562799</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizkarguenaga M., Bruzzone C., Gil-Redondo R., SanJuan I., Martin-Ruiz I., Barriales D., et al. (2022). Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics. NMR Biomed. 35, 46377&#x2013;e4710. 10.1002/nbm.4637</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.4637</ArticleId><ArticleId IdType="pmc">PMC8646702</ArticleId><ArticleId IdType="pubmed">34708437</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Bessy C., Plantier L., Lefevre A., Piver E., Bernard L., et al. (2020). The specific metabolome profiling of patients infected by SARS-COV-2 supports the key role of tryptophan-nicotinamide pathway and cytosine metabolism. Sci. Rep. 10, 16824&#x2013;16912. 10.1038/s41598-020-73966-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-73966-5</ArticleId><ArticleId IdType="pmc">PMC7544910</ArticleId><ArticleId IdType="pubmed">33033346</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone C., Bizkarguenaga M., Gil-Redondo R., Diercks T., Arana E., Garc&#xed;a de Vicu&#xf1;a A., et al. (2020). SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum. iScience 23, 101645. 10.1016/j.isci.2020.101645</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2020.101645</ArticleId><ArticleId IdType="pmc">PMC7534591</ArticleId><ArticleId IdType="pubmed">33043283</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruzzone C., Gil-Redondo R., Seco M., Barrag&#xe1;n R., de la Cruz L., Cannet C., et al. (2021). A molecular signature for the metabolic syndrome by urine metabolomics. Cardiovasc Diabetol. 20, 155. 10.1186/s12933-021-01349-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01349-9</ArticleId><ArticleId IdType="pmc">PMC8320177</ArticleId><ArticleId IdType="pubmed">34320987</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyukozkan M., Alvarez-Mulett S., Racanelli A. C., Schmidt F., Batra R., Hoffman K. L., et al. (2022). Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19. iScience 25, 104612. 10.1016/j.isci.2022.104612</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104612</ArticleId><ArticleId IdType="pmc">PMC9212983</ArticleId><ArticleId IdType="pubmed">35756895</ArticleId></ArticleIdList></Reference><Reference><Citation>Byeon S. K., Madugundu A. K., Garapati K., Ramarajan M. G., Saraswat M., Kumar-M , P., et al. (2022). Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: A retrospective cohort study. Lancet Digit. Health 4, e632&#x2013;e645. 10.1016/S2589-7500(22)00112-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00112-1</ArticleId><ArticleId IdType="pmc">PMC9273185</ArticleId><ArticleId IdType="pubmed">35835712</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Y., Kim D. J., Takahashi T., Broadhurst D. I., Yan H., Ma S., et al. (2021). Kynurenic acid may underlie sex-specific immune responses to COVID-19. Sci. Signal 14, eabf8483&#x2013;11. 10.1126/scisignal.abf8483</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.abf8483</ArticleId><ArticleId IdType="pmc">PMC8432948</ArticleId><ArticleId IdType="pubmed">34230210</ArticleId></ArticleIdList></Reference><Reference><Citation>Casta&#xf1;&#xe9; H., Iftimie S., Baiges-Gaya G., Rodr&#xed;guez-Tom&#xe0;s E., Jim&#xe9;nez-Franco A., L&#xf3;pez-Azcona A. F., et al. (2022). Machine learning and semi-targeted lipidomics identify distinct serum lipid signatures in hospitalized COVID-19-positive and COVID-19-negative patients. Metabolism 131, 155197. 10.1016/j.metabol.2022.155197</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2022.155197</ArticleId><ArticleId IdType="pmc">PMC8976580</ArticleId><ArticleId IdType="pubmed">35381232</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterino M., Costanzo M., Fedele R., Cevenini A., Gelzo M., Di Minno A., et al. (2021a). The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism. Int. J. Mol. Sci. 22, 9548. 10.3390/IJMS22179548</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/IJMS22179548</ArticleId><ArticleId IdType="pmc">PMC8431319</ArticleId><ArticleId IdType="pubmed">34502454</ArticleId></ArticleIdList></Reference><Reference><Citation>Caterino M., Gelzo M., Sol S., Fedele R., Annunziata A., Calabrese C., et al. (2021b). Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci. Rep. 11, 2941. 10.1038/s41598-021-82426-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-82426-7</ArticleId><ArticleId IdType="pmc">PMC7859398</ArticleId><ArticleId IdType="pubmed">33536486</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos F. C., Virseda-Berdices A., Resino S., Ryan P., Mart&#xed;nez-Gonz&#xe1;lez O., Per&#xe9;z-Garc&#xed;a F., et al. (2022). Metabolic profiling at COVID-19 onset shows disease severity and sex-specific dysregulation. Front. Immunol. 13, 925558&#x2013;925616. 10.3389/fimmu.2022.925558</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.925558</ArticleId><ArticleId IdType="pmc">PMC9280146</ArticleId><ArticleId IdType="pubmed">35844615</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Yao M., Chen M., Ou Z., Yang Q., He Y., et al. (2022). Using an untargeted metabolomics approach to analyze serum metabolites in COVID-19 patients with nucleic acid turning negative. Front. Pharmacol. 13, 964037&#x2013;964112. 10.3389/fphar.2022.964037</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.964037</ArticleId><ArticleId IdType="pmc">PMC9449332</ArticleId><ArticleId IdType="pubmed">36091834</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccarelli M., Merciai F., Carrizzo A., Sommella E., Di Pietro P., Caponigro V., et al. (2022). Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy). J. Pharm. Biomed. Anal. 217, 114827. 10.1016/j.jpba.2022.114827</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpba.2022.114827</ArticleId><ArticleId IdType="pmc">PMC9085356</ArticleId><ArticleId IdType="pubmed">35569273</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciotti M., Ciccozzi M., Terrinoni A., Jiang W. C., Wang C. B., Bernardini S. (2020). The COVID-19 pandemic. Crit. Rev. Clin. Lab. Sci. 57, 365&#x2013;388. 10.1080/10408363.2020.1783198</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1783198</ArticleId><ArticleId IdType="pubmed">32645276</ArticleId></ArticleIdList></Reference><Reference><Citation>Coperchini F., Chiovato L., Croce L., Magri F., Rotondi M. (2020). The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 53, 25&#x2013;32. 10.1016/j.cytogfr.2020.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2020.05.003</ArticleId><ArticleId IdType="pmc">PMC7211650</ArticleId><ArticleId IdType="pubmed">32446778</ArticleId></ArticleIdList></Reference><Reference><Citation>Correia B. S. B., Ferreira V. G., Piagge P. M. F. D., Almeida M. B., Assun&#xe7;&#xe3;o N. A., Raimundo J. R. S., et al. (2022). 1H qNMR-based metabolomics discrimination of covid-19 severity. J. Proteome Res. 21, 1640&#x2013;1653. 10.1021/acs.jproteome.1c00977</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00977</ArticleId><ArticleId IdType="pubmed">35674498</ArticleId></ArticleIdList></Reference><Reference><Citation>Costanzo M., Caterino M., Fedele R., Cevenini A., Pontillo M., Barra L., et al. (2022). COVIDomics: The proteomic and metabolomic signatures of COVID-19. Int. J. Mol. Sci. 23, 2414. 10.3390/ijms23052414</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23052414</ArticleId><ArticleId IdType="pmc">PMC8910221</ArticleId><ArticleId IdType="pubmed">35269564</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruzat V., Rogero M. M., Keane K. N., Curi R., Newsholme P. (2018). Glutamine: Metabolism and immune function, supplementation and clinical translation. Nutrients 10, 1564. 10.3390/NU10111564</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/NU10111564</ArticleId><ArticleId IdType="pmc">PMC6266414</ArticleId><ArticleId IdType="pubmed">30360490</ArticleId></ArticleIdList></Reference><Reference><Citation>Cucinotta D., Vanelli M. (2020). WHO declares COVID-19 a pandemic. Acta Biomed. 91, 157&#x2013;160. 10.23750/abm.v91i1.9397</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagla I., Iliou A., Benaki D., Gikas E., Mikros E., Bagratuni T., et al. (2022). Plasma metabolomic alterations induced by COVID-19 vaccination reveal putative biomarkers reflecting the immune response. Cells 11, 1241. 10.3390/cells11071241</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11071241</ArticleId><ArticleId IdType="pmc">PMC8997405</ArticleId><ArticleId IdType="pubmed">35406806</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;alessandro A., Thomas T., Akpan I. J., Reisz J. A., Cendali F. I., Gamboni F., et al. (2021). Biological and clinical factors contributing to the metabolic heterogeneity of hospitalized patients with and without Covid-19. Cells 10, 2293&#x2013;2323. 10.3390/cells10092293</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10092293</ArticleId><ArticleId IdType="pmc">PMC8467961</ArticleId><ArticleId IdType="pubmed">34571942</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amora P., Silva I. D. C. G., Budib M. A., Ayache R., Silva R. M. S., Silva F. C., et al. (2021). Towards risk stratification and prediction of disease severity and mortality in COVID-19: Next generation metabolomics for the measurement of host response to COVID-19 infection. PLoS One 16, e0259909&#x2013;e0259916. 10.1371/journal.pone.0259909</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259909</ArticleId><ArticleId IdType="pmc">PMC8635335</ArticleId><ArticleId IdType="pubmed">34851990</ArticleId></ArticleIdList></Reference><Reference><Citation>Danlos F. X., Grajeda-Iglesias C., Durand S., Sauvat A., Roumier M., Cantin D., et al. (2021). Metabolomic analyses of COVID-19 patients unravel stage-dependent and prognostic biomarkers. Cell Death Dis. 12, 258. 10.1038/s41419-021-03540-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-021-03540-y</ArticleId><ArticleId IdType="pmc">PMC7948172</ArticleId><ArticleId IdType="pubmed">33707411</ArticleId></ArticleIdList></Reference><Reference><Citation>Darcy C. J., Davis J. S., Woodberry T., McNeil Y. R., Stephens D. P., Yeo T. W., et al. (2011). An observational cohort study of the kynurenine to tryptophan ratio in sepsis: Association with impaired immune and microvascular function. PLoS One 6, e21185. 10.1371/journal.pone.0021185</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021185</ArticleId><ArticleId IdType="pmc">PMC3120841</ArticleId><ArticleId IdType="pubmed">21731667</ArticleId></ArticleIdList></Reference><Reference><Citation>Dei Cas M., Ottolenghi S., Morano C., Rinaldo R., Roda G., Chiumello D., et al. (2021). Link between serum lipid signature and prognostic factors in COVID-19 patients. Sci. Rep. 11, 21633&#x2013;21712. 10.1038/s41598-021-00755-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00755-z</ArticleId><ArticleId IdType="pmc">PMC8568966</ArticleId><ArticleId IdType="pubmed">34737330</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewulf J. P., Martin M., Marie S., Oguz F., Belkhir L., De Greef J., et al. (2022). Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19. Sci. Rep. 12, 9959&#x2013;9968. 10.1038/s41598-022-14292-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-14292-w</ArticleId><ArticleId IdType="pmc">PMC9198612</ArticleId><ArticleId IdType="pubmed">35705608</ArticleId></ArticleIdList></Reference><Reference><Citation>Diboun I., Cyprian F. S., Anwardeen N. R., Yassine H. M., Elrayess M. A., Rahmoon S. M., et al. (2022). Identification of prognostic metabolomic biomarkers at the interface of mortality and morbidity in pre-existing TB cases infected with SARS-CoV-2. Front. Cell Infect. Microbiol. 12, 929689&#x2013;929713. 10.3389/fcimb.2022.929689</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.929689</ArticleId><ArticleId IdType="pmc">PMC9354137</ArticleId><ArticleId IdType="pubmed">35937683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dillard L. R., Wase N., Ramakrishnan G., Park J. J., Sherman N. E., Carpenter R., et al. (2022). Leveraging metabolic modeling to identify functional metabolic alterations associated with COVID-19 disease severity. Metabolomics 18, 51&#x2013;14. 10.1007/s11306-022-01904-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-022-01904-9</ArticleId><ArticleId IdType="pmc">PMC9273921</ArticleId><ArticleId IdType="pubmed">35819731</ArticleId></ArticleIdList></Reference><Reference><Citation>Do&#x11f;an H. O., &#x15e;enol O., Bolat S., Y&#x131;ld&#x131;z &#x15e;. N., B&#xfc;y&#xfc;ktuna S. A., Sar&#x131;ismailo&#x11f;lu R., et al. (2021). Understanding the pathophysiological changes via untargeted metabolomics in COVID-19 patients. J. Med. Virol. 93, 2340&#x2013;2349. 10.1002/jmv.26716</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26716</ArticleId><ArticleId IdType="pubmed">33300133</ArticleId></ArticleIdList></Reference><Reference><Citation>Esakandari H., Nabi-Afjadi M., Fakkari-Afjadi J., Farahmandian N., Miresmaeili S. M., Bahreini E. (2020). A comprehensive review of COVID-19 characteristics. Biol. Proced. Online 22, 19&#x2013;10. 10.1186/s12575-020-00128-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12575-020-00128-2</ArticleId><ArticleId IdType="pmc">PMC7402395</ArticleId><ArticleId IdType="pubmed">32774178</ArticleId></ArticleIdList></Reference><Reference><Citation>Escarcega R. D., Honarpisheh P., Colpo G. D., Ahnstedt H. W., Couture L., Juneja S., et al. (2022). Sex differences in global metabolomic profiles of COVID-19 patients. Cell Death Dis. 13, 461. 10.1038/s41419-022-04861-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04861-2</ArticleId><ArticleId IdType="pmc">PMC9106988</ArticleId><ArticleId IdType="pubmed">35568706</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernstrom J. D., Wurtman R. J. (1971). Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173, 149&#x2013;152. 10.1126/science.173.3992.149</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.173.3992.149</ArticleId><ArticleId IdType="pubmed">5581909</ArticleId></ArticleIdList></Reference><Reference><Citation>Frampas C. F., Longman K., Spick M., Lewis H. M., Costa C. D. S., Stewart A., et al. (2022). Untargeted saliva metabolomics by liquid chromatography-Mass spectrometry reveals markers of COVID-19 severity. PLoS One 17. e0274967. 10.1371/journal.pone.0274967</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274967</ArticleId><ArticleId IdType="pmc">PMC9498978</ArticleId><ArticleId IdType="pubmed">36137157</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo Marin B., Aghagoli G., Lavine K., Yang L., Siff E. J., Chiang S. S., et al. (2021). Predictors of COVID-19 severity: A literature review. Rev. Med. Virol. 31, 1&#x2013;10. 10.1002/rmv.2146</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2146</ArticleId><ArticleId IdType="pmc">PMC7855377</ArticleId><ArticleId IdType="pubmed">32845042</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V., Maggi L., Mazzoni A., Spinicci M., Zammarchi L., Bartoloni A., et al. (2022a). Serum NMR profiling reveals differential alterations in the lipoproteome induced by pfizer-BioNTech vaccine in COVID-19 recovered subjects and na&#xef;ve subjects. Front. Mol. Biosci. 9, 839809&#x2013;839818. 10.3389/fmolb.2022.839809</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.839809</ArticleId><ArticleId IdType="pmc">PMC9037139</ArticleId><ArticleId IdType="pubmed">35480886</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghini V., Meoni G., Pelagatti L., Celli T., Veneziani F., Petrucci F., et al. (2022b). Profiling metabolites and lipoproteins in COMETA, an Italian cohort of COVID-19 patients. PLoS Pathog. 18, 10104433&#x2013;e1010516. 10.1371/journal.ppat.1010443</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010443</ArticleId><ArticleId IdType="pmc">PMC9022834</ArticleId><ArticleId IdType="pubmed">35446921</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassin-Delyle S., Roquencourt C., Moine P., Saffroy G., Carn S., Heming N., et al. (2021). Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study. EBioMedicine 63, 103154. 10.1016/j.ebiom.2020.103154</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2020.103154</ArticleId><ArticleId IdType="pmc">PMC7714658</ArticleId><ArticleId IdType="pubmed">33279860</ArticleId></ArticleIdList></Reference><Reference><Citation>Gray N., Lawler N., Zeng A., Ryan M., Bong S., Boughton B., et al. (2021). Diagnostic potential of the plasma lipidome in infectious disease: Application to acute SARS-CoV-2 infection. Metabolites 11, 467. 10.3390/metabo11070467</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo11070467</ArticleId><ArticleId IdType="pmc">PMC8306636</ArticleId><ArticleId IdType="pubmed">34357361</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu M., Pan H., Yuan Y., Zhou X., Chen L., Wang X., et al. (2022). Sera metabolomics characterization of patients at different stages in wuhan identifies critical biomarkers of COVID-19. Front. Cell Infect. Microbiol. 12, 882661&#x2013;882715. 10.3389/fcimb.2022.882661</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.882661</ArticleId><ArticleId IdType="pmc">PMC9108257</ArticleId><ArticleId IdType="pubmed">35586248</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Y., Zhang Z., Feng G., Chen M., Wan Q., Lin J., et al. (2021). Distinct lipid metabolic dysregulation in asymptomatic COVID-19. iScience 24. 102974. 10.1016/j.isci.2021.102974</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102974</ArticleId><ArticleId IdType="pmc">PMC8356725</ArticleId><ArticleId IdType="pubmed">34396083</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan M. R., Suleiman M., P&#xe9;rez-L&#xf3;pez A. (2021). Metabolomics in the diagnosis and prognosis of COVID-19. Front. Genet. 12, 721556. 10.3389/fgene.2021.721556</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2021.721556</ArticleId><ArticleId IdType="pmc">PMC8343128</ArticleId><ArticleId IdType="pubmed">34367265</ArticleId></ArticleIdList></Reference><Reference><Citation>He F., Zhang T., Xue K., Fang Z., Jiang G., Huang S., et al. (2021). Fecal multi-omics analysis reveals diverse molecular alterations of gut ecosystem in COVID-19 patients. Anal. Chim. Acta 1180, 338881. 10.1016/j.aca.2021.338881</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338881</ArticleId><ArticleId IdType="pmc">PMC8310733</ArticleId><ArticleId IdType="pubmed">34538334</ArticleId></ArticleIdList></Reference><Reference><Citation>He M., Huang Y., Wang Y., Liu J., Han M., Xiao Y., et al. (2022). Metabolomics-based investigation of SARS-CoV-2 vaccination (Sinovac) reveals an immune-dependent metabolite biomarker. Front. Immunol. 13, 954801&#x2013;954814. 10.3389/fimmu.2022.954801</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.954801</ArticleId><ArticleId IdType="pmc">PMC9554639</ArticleId><ArticleId IdType="pubmed">36248825</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E., Wist J., Masuda R., Lodge S., Nitschke P., Kimhofer T., et al. (2021b). Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: Implications for assessment of post-acute COVID-19 syndrome. J. Proteome Res. 20, 3315&#x2013;3329. 10.1021/acs.jproteome.1c00224</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E., Nicholson J. K., Lodge S., Nitschke P., Kimhofer T., Wist J., et al. (2021a). Diffusion and relaxation edited proton NMR spectroscopy of plasma reveals a high-fidelity supramolecular biomarker signature of SARS-CoV-2 infection. Anal. Chem. 93, 3976&#x2013;3986. 10.1021/acs.analchem.0c04952</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c04952</ArticleId><ArticleId IdType="pubmed">33577736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibarra-gonza I., Mart L. E., Tusie T., Moreno-mac H., Jimenez-gutierrez G. E., Va P., et al. (2022). Metabolic reprogramming in SARS-CoV-2 infection impacts the outcome of COVID-19 patients. Front. Immunol. 13, 936106&#x2013;936112. 10.3389/fimmu.2022.936106</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.936106</ArticleId><ArticleId IdType="pmc">PMC9634751</ArticleId><ArticleId IdType="pubmed">36341434</ArticleId></ArticleIdList></Reference><Reference><Citation>Id M. A., Mok T., Id C. J., Yeo S., Quach A., Id Y. A. (2022). Severe COVID-19 in pregnancy has a distinct serum profile, including greater complement activation and dysregulation of serum lipids. 1&#x2013;12. doi: 10.1371/journal.pone.0276766</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0276766</ArticleId><ArticleId IdType="pmc">PMC9668183</ArticleId><ArticleId IdType="pubmed">36383608</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson C. B., Farzan M., Chen B., Choe H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3&#x2013;20. 10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Janneh A. H., Kassir M. F., Dwyer C. J., Chakraborty P., Pierce J. S., Flume P. A., et al. (2021). Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients. Sci. Rep. 11, 14232. 10.1038/s41598-021-93857-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93857-7</ArticleId><ArticleId IdType="pmc">PMC8270895</ArticleId><ArticleId IdType="pubmed">34244584</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing Y., Wang J., Zhang H., Yang K., Li J., Zhao T., et al. (2022). Alterations of urinary microbial metabolites and immune indexes linked with COVID-19 infection and prognosis. Front. Immunol. 13, 841739. 10.3389/fimmu.2022.841739</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.841739</ArticleId><ArticleId IdType="pmc">PMC9001849</ArticleId><ArticleId IdType="pubmed">35422810</ArticleId></ArticleIdList></Reference><Reference><Citation>Julkunen H., Cicho&#x144;ska A., Slagboom P. E., W&#xfc;rtz P. (2021). Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population. Elife 10, 630333&#x2013;e63120. 10.7554/eLife.63033</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.63033</ArticleId><ArticleId IdType="pmc">PMC8172246</ArticleId><ArticleId IdType="pubmed">33942721</ArticleId></ArticleIdList></Reference><Reference><Citation>Karu N., Kindt A., Lamont L., van Gammeren A. J., Ermens A. A. M., Harms A. C., et al. (2022). Plasma oxylipins and their precursors are strongly associated with COVID-19 severity and with immune response markers. Metabolites 12, 619&#x2013;710. 10.3390/metabo12070619</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070619</ArticleId><ArticleId IdType="pmc">PMC9319897</ArticleId><ArticleId IdType="pubmed">35888743</ArticleId></ArticleIdList></Reference><Reference><Citation>Khodadoust M. M. (2021). Inferring a causal relationship between ceramide levels and COVID-19 respiratory distress. Sci. Rep. 11, 20866&#x2013;20913. 10.1038/s41598-021-00286-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-00286-7</ArticleId><ArticleId IdType="pmc">PMC8531370</ArticleId><ArticleId IdType="pubmed">34675292</ArticleId></ArticleIdList></Reference><Reference><Citation>Kida M., Nakamura T., Kobayashi K., Shimosawa T., Murata T. (2022). Urinary lipid profile of patients with coronavirus diseases 2019. Front. Med. (Lausanne) 9, 941563&#x2013;941567. 10.3389/fmed.2022.941563</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.941563</ArticleId><ArticleId IdType="pmc">PMC9548532</ArticleId><ArticleId IdType="pubmed">36226145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimhofer T., Lodge S., Whiley L., Gray N., Loo R. L., Lawler N. G., et al. (2020). Integrative modeling of quantitative plasma lipoprotein, metabolic, and amino acid data reveals a multiorgan pathological signature of SARS-CoV-2 infection. J. Proteome Res. 19, 4442&#x2013;4454. 10.1021/acs.jproteome.0c00519</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00519</ArticleId><ArticleId IdType="pubmed">32806897</ArticleId></ArticleIdList></Reference><Reference><Citation>Kinscherf R., Hack V., Fischbach T., Friedmann B., Weiss C., Edler L., et al. (1996). Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: The effect of N- acetyl-cysteine. J. Mol. Med. 74, 393&#x2013;400. 10.1007/BF00210633</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00210633</ArticleId><ArticleId IdType="pubmed">8841951</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig I. R., Fuchs O., Hansen G., von Mutius E., Kopp M. V. (2017). What is precision medicine? Eur. Respir. J. 50, 1700391&#x2013;1700412. 10.1183/13993003.00391-2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00391-2017</ArticleId><ArticleId IdType="pubmed">29051268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kontou A., Virgiliou C., Mouskeftara T., Begou O., Meikopoulos T., Thomaidou A., et al. (2021). Plasma lipidomic and metabolomic profiling after birth in neonates born to SARS-CoV-19 infected and non-infected mothers at delivery: Preliminary results. Metabolites 11, 830&#x2013;914. 10.3390/METABO11120830</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/METABO11120830</ArticleId><ArticleId IdType="pmc">PMC8706054</ArticleId><ArticleId IdType="pubmed">34940588</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurano M., Aoki J., Moriya K. (2022a). Dynamic modulations of sphingolipids and glycerophospholipids in COVID-19. doi: 10.1002/ctm2.1069</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.1069</ArticleId><ArticleId IdType="pmc">PMC9549873</ArticleId><ArticleId IdType="pubmed">36214754</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurano M., Jubishi D., Okamoto K., Hashimoto H., Sakai E., Morita Y., et al. (2022b). Dynamic modulations of urinary sphingolipid and glycerophospholipid levels in COVID-19 and correlations with COVID-19-associated kidney injuries. J. Biomed. Sci. 29, 94. 10.1186/s12929-022-00880-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-022-00880-5</ArticleId><ArticleId IdType="pmc">PMC9647768</ArticleId><ArticleId IdType="pubmed">36357929</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam S. M., Zhang C., Wang Z., Ni Z., Zhang S., Yang S., et al. (2021). A multi-omics investigation of the composition and function of extracellular vesicles along the temporal trajectory of COVID-19. Nat. Metab. 3, 909&#x2013;922. 10.1038/s42255-021-00425-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42255-021-00425-4</ArticleId><ArticleId IdType="pubmed">34158670</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis H. M., Liu Y., Frampas C. F., Longman K., Spick M., Stewart A., et al. (2022). Metabolomics markers of COVID-19 are dependent on collection wave. Metabolites 12, 713. 10.3390/metabo12080713</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12080713</ArticleId><ArticleId IdType="pmc">PMC9415837</ArticleId><ArticleId IdType="pubmed">36005585</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F., Fu L., Liu X., Liu X. A., Liang Y., Lv Y., et al. (2022a). Serum metabolomic abnormalities in survivors of non-severe COVID-19. Heliyon 8, e10473. 10.1016/j.heliyon.2022.e10473</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2022.e10473</ArticleId><ArticleId IdType="pmc">PMC9433334</ArticleId><ArticleId IdType="pubmed">36065322</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Li X., Wu Q., Wang X., Qin Z., Wang Y., et al. (2022b). Plasma proteomic and metabolomic characterization of COVID-19 survivors 6 months after discharge. Cell Death Dis. 13, 235. 10.1038/s41419-022-04674-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-022-04674-3</ArticleId><ArticleId IdType="pmc">PMC8919172</ArticleId><ArticleId IdType="pubmed">35288537</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T., Ning N., Li B., Luo D., Qin E., Yu W., et al. (2021a). Longitudinal metabolomics reveals ornithine cycle dysregulation correlates with inflammation and coagulation in COVID-19 severe patients. Front. Microbiol. 12, 723818&#x2013;723912. 10.3389/fmicb.2021.723818</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.723818</ArticleId><ArticleId IdType="pmc">PMC8678452</ArticleId><ArticleId IdType="pubmed">34925252</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W., Moore M. J., Vasilieva N., Sui J., Wong S. K., Berne M. A., et al. (2003). Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450&#x2013;454. 10.1038/nature02145</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02145</ArticleId><ArticleId IdType="pmc">PMC7095016</ArticleId><ArticleId IdType="pubmed">14647384</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Tu B., Zhang X., Xu W., Chen J., Xu B., et al. (2022c). Dysregulation of glutamine/glutamate metabolism in COVID-19 patients: A metabolism study in african population and mini meta-analysis. J. Med. Virol. 0, e28150&#x2013;e28152. 10.1002/jmv.28150</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28150</ArticleId><ArticleId IdType="pmc">PMC9538869</ArticleId><ArticleId IdType="pubmed">36112136</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y., Hou G., Zhou H., Wang Y., Tun H. M., Zhu A., et al. (2021b). Multi-platform omics analysis reveals molecular signature for COVID-19 pathogenesis, prognosis and drug target discovery. Signal Transduct. Target Ther. 6, 155. 10.1038/s41392-021-00508-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00508-4</ArticleId><ArticleId IdType="pmc">PMC8047575</ArticleId><ArticleId IdType="pubmed">33859163</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin B., Liu J., Liu Y., Qin X. (2021). Progress in understanding COVID-19: Insights from the omics approach. Crit. Rev. Clin. Lab. Sci. 58, 242&#x2013;252. 10.1080/10408363.2020.1851167</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1851167</ArticleId><ArticleId IdType="pubmed">33375876</ArticleId></ArticleIdList></Reference><Reference><Citation>Liptak P., Baranovicova E., Rosolanka R., Simekova K., Bobcakova A., Vysehradsky R., et al. (2022). Persistence of metabolomic changes in patients during post-COVID phase: A prospective, observational study. Metabolites 12, 641. 10.3390/metabo12070641</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12070641</ArticleId><ArticleId IdType="pmc">PMC9321209</ArticleId><ArticleId IdType="pubmed">35888766</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li Z. B., Lu Q. Q., Yu Y., Zhang S. Q., Ke P. F., et al. (2022). Metabolite profile of COVID-19 revealed by UPLC-MS/MS-based widely targeted metabolomics. Front. Immunol. 13, 894170&#x2013;894213. 10.3389/fimmu.2022.894170</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.894170</ArticleId><ArticleId IdType="pmc">PMC9339702</ArticleId><ArticleId IdType="pubmed">35924246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge S., Nitschke P., Kimhofer T., Coudert J. D., Begum S., Bong S. H., et al. (2021a). NMR spectroscopic windows on the systemic effects of SARS-CoV-2 infection on plasma lipoproteins and metabolites in relation to circulating cytokines. J. Proteome Res. 20, 1382&#x2013;1396. 10.1021/acs.jproteome.0c00876</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00876</ArticleId><ArticleId IdType="pubmed">33426894</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge S., Nitschke P., Kimhofer T., Wist J., Bong S.-H., Loo R. L., et al. (2021b). Diffusion and relaxation edited proton NMR spectroscopy of plasma reveals a high-fidelity supramolecular biomarker signature of SARS-CoV-2 infection. Anal. Chem. 93, 3976&#x2013;3986. 10.1021/acs.analchem.0c04952</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.0c04952</ArticleId><ArticleId IdType="pubmed">33577736</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodge S., Nitschke P., Loo R. L., Kimhofer T., Bong S.-H., Richards T., et al. (2021c). Low volume in vitro diagnostic proton NMR spectroscopy of human blood plasma for lipoprotein and metabolite analysis: Application to SARS-CoV-2 biomarkers. J. Proteome Res. 20, 1415&#x2013;1423. 10.1021/acs.jproteome.0c00815</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00815</ArticleId><ArticleId IdType="pubmed">33491459</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Hern&#xe1;ndez Y., Mon&#xe1;rrez-Espino J., Oostdam A. S. H., Delgado J. E. C., Zhang L., Zheng J., et al. (2021). Targeted metabolomics identifies high performing diagnostic and prognostic biomarkers for COVID-19. Sci. Rep. 11, 14732&#x2013;14813. 10.1038/s41598-021-94171-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-94171-y</ArticleId><ArticleId IdType="pmc">PMC8290000</ArticleId><ArticleId IdType="pubmed">34282210</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorente J. A., Nin N., Villa P., Vasco D., Miguel-Coello A. B., Rodriguez I., et al. (2021). Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS. Crit. Care 25, 390&#x2013;411. 10.1186/s13054-021-03810-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03810-3</ArticleId><ArticleId IdType="pmc">PMC8591432</ArticleId><ArticleId IdType="pubmed">34781986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv L., Jiang H., Chen Y., Gu S., Xia J., Zhang H., et al. (2021). The faecal metabolome in COVID-19 patients is altered and associated with clinical features and gut microbes. Anal. Chim. Acta 1152, 338267. 10.1016/j.aca.2021.338267</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.aca.2021.338267</ArticleId><ArticleId IdType="pmc">PMC7847702</ArticleId><ArticleId IdType="pubmed">33648648</ArticleId></ArticleIdList></Reference><Reference><Citation>Mar&#xed;n-Corral J., Rodr&#xed;guez-Morat&#xf3; J., Gomez-Gomez A., Pascual-Guardia S., Mu&#xf1;oz-Berm&#xfa;dez R., Salazar-Degracia A., et al. (2021). Metabolic signatures associated with severity in hospitalized Covid-19 patients. Int. J. Mol. Sci. 22, 4794. 10.3390/ijms22094794</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094794</ArticleId><ArticleId IdType="pmc">PMC8124482</ArticleId><ArticleId IdType="pubmed">33946479</ArticleId></ArticleIdList></Reference><Reference><Citation>Masoodi M., Peschka M., Schmiedel S., Haddad M., Frye M., Maas C., et al. (2022). Disturbed lipid and amino acid metabolisms in COVID-19 patients. J. Mol. Med. 100, 555&#x2013;568. 10.1007/s00109-022-02177-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-022-02177-4</ArticleId><ArticleId IdType="pmc">PMC8783191</ArticleId><ArticleId IdType="pubmed">35064792</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda R., Lodge S., Nitschke P., Spraul M., Schaefer H., Bong S.-H., et al. (2021). Integrative modeling of plasma metabolic and lipoprotein biomarkers of SARS-CoV-2 infection in Spanish and Australian COVID-19 patient cohorts. J. Proteome Res. 20, 4139&#x2013;4152. 10.1021/acs.jproteome.1c00458</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00458</ArticleId><ArticleId IdType="pubmed">34251833</ArticleId></ArticleIdList></Reference><Reference><Citation>Masuda R., Lodge S., Whiley L., Gray N., Lawler N., Nitschke P., et al. (2022). Exploration of human serum lipoprotein supramolecular phospholipids using statistical heterospectroscopy in n-dimensions (SHY- n): Identification of potential cardiovascular risk biomarkers related to SARS-CoV-2 infection. Anal. Chem. 94, 4426&#x2013;4436. 10.1021/acs.analchem.1c05389</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.1c05389</ArticleId><ArticleId IdType="pubmed">35230805</ArticleId></ArticleIdList></Reference><Reference><Citation>Meoni G., Ghini V., Maggi L., Vignoli A., Mazzoni A., Salvati L., et al. (2021). Metabolomic/lipidomic profiling of COVID-19 and individual response to tocilizumab. PLoS Pathog. 17, 10092433&#x2013;e1009314. 10.1371/JOURNAL.PPAT.1009243</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/JOURNAL.PPAT.1009243</ArticleId><ArticleId IdType="pmc">PMC7877736</ArticleId><ArticleId IdType="pubmed">33524041</ArticleId></ArticleIdList></Reference><Reference><Citation>Montazersaheb S., Hosseiniyan Khatibi S. M., Hejazi M. S., Tarhriz V., Farjami A., Ghasemian Sorbeni F., et al. (2022). COVID-19 infection: An overview on cytokine storm and related interventions. Virol. J. 19, 92&#x2013;15. 10.1186/s12985-022-01814-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-022-01814-1</ArticleId><ArticleId IdType="pmc">PMC9134144</ArticleId><ArticleId IdType="pubmed">35619180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson J. K. (2021). Molecular phenomic approaches to deconvolving the systemic effects of SARS-CoV-2 infection and post-acute COVID-19 syndrome. Phenomics 1, 143&#x2013;150. 10.1007/S43657-021-00020-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S43657-021-00020-3</ArticleId><ArticleId IdType="pmc">PMC8295979</ArticleId><ArticleId IdType="pubmed">35233558</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson J. K., Lindon J. C. (2008). Systems biology: Metabonomics. Metabonomics 455, 1054&#x2013;1056. 10.1038/4551054a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4551054a</ArticleId><ArticleId IdType="pubmed">18948945</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitschke P., Lodge S., Hall D., Schaefer H., Spraul M., Embade N., et al. (2022a). Direct low field J-edited diffusional proton NMR spectroscopic measurement of COVID-19 inflammatory biomarkers in human serum. Analyst 147, 4213&#x2013;4221. 10.1039/d2an01097f</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/d2an01097f</ArticleId><ArticleId IdType="pubmed">35994017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nitschke P., Lodge S., Kimhofer T., Masuda R., Bong S. H., Hall D., et al. (2022b). J-edited DIffusional proton nuclear magnetic resonance spectroscopic measurement of glycoprotein and supramolecular phospholipid biomarkers of inflammation in human serum. Anal. Chem. 94, 1333&#x2013;1341. 10.1021/acs.analchem.1c04576</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.1c04576</ArticleId><ArticleId IdType="pubmed">34985268</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira L. B., Mwangi V. I., Sartim M. A., Delafiori J., Sales G. M., de Oliveira A. N., et al. (2022). Metabolomic profiling of plasma reveals differential disease severity markers in COVID-19 patients. Front. Microbiol. 13, 844283&#x2013;844315. 10.3389/fmicb.2022.844283</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.844283</ArticleId><ArticleId IdType="pmc">PMC9094083</ArticleId><ArticleId IdType="pubmed">35572676</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;ez-Franco J. C., Maravillas-Montero J. L., Mej&#xed;a-Dom&#xed;nguez N. R., Torres-Ruiz J., Tamez-Torres K. M., P&#xe9;rez-Fragoso A., et al. (2022). Metabolomics analysis identifies glutamic acid and cystine imbalances in COVID-19 patients without comorbid conditions. Implications on redox homeostasis and COVID-19 pathophysiology. PLoS One 17, e0274910. 10.1371/journal.pone.0274910</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274910</ArticleId><ArticleId IdType="pmc">PMC9488784</ArticleId><ArticleId IdType="pubmed">36126080</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe1;ez-Franco J. C., Torres-Ruiz J., Sosa-Hern&#xe1;ndez V. A., Cervantes-D&#xed;az R., Romero-Ram&#xed;rez S., P&#xe9;rez-Fragoso A., et al. (2021). Metabolomics analysis reveals a modified amino acid metabolism that correlates with altered oxygen homeostasis in COVID-19 patients. Sci. Rep. 11, 6350&#x2013;6412. 10.1038/s41598-021-85788-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-85788-0</ArticleId><ArticleId IdType="pmc">PMC7973513</ArticleId><ArticleId IdType="pubmed">33737694</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan Z., Raftery D. (2007). Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal. Bioanal. Chem. 387, 525&#x2013;527. 10.1007/s00216-006-0687-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-006-0687-8</ArticleId><ArticleId IdType="pubmed">16955259</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez M. M., Pimentel V. E., Fuzo C. A., da Silva-Neto P. V., Toro D. M., Fraga-Silva T. F. C., et al. (2022). Acetylcholine, fatty acids, and lipid mediators are linked to COVID-19 severity. J. Immunol. 209, 250&#x2013;261. 10.4049/jimmunol.2200079</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.2200079</ArticleId><ArticleId IdType="pubmed">35768148</ArticleId></ArticleIdList></Reference><Reference><Citation>Remy R., Kemnitz N., Trefz P., Fuchs P., Bartels J., Klemenz A.-C., et al. (2022). Profiling of exhaled volatile organics in the screening scenario of a COVID-19 test center. iScience 25, 105195. 10.1016/j.isci.2022.105195</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.105195</ArticleId><ArticleId IdType="pmc">PMC9502439</ArticleId><ArticleId IdType="pubmed">36168390</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren Z., Wang H., Cui G., Lu H., Wang L., Luo H., et al. (2021). Alterations in the human oral and gut microbiomes and lipidomics in COVID-19. Gut 70, 1253&#x2013;1265. 10.1136/gutjnl-2020-323826</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323826</ArticleId><ArticleId IdType="pmc">PMC8042598</ArticleId><ArticleId IdType="pubmed">33789966</ArticleId></ArticleIdList></Reference><Reference><Citation>Rendeiro A. F., Vorkas C. K., Krumsiek J., Singh H. K., Kapadia S. N., Cappelli L. V., et al. (2022). Metabolic and immune markers for precise monitoring of COVID-19 severity and treatment. Front. Immunol. 12, 809937&#x2013;810013. 10.3389/fimmu.2021.809937</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.809937</ArticleId><ArticleId IdType="pmc">PMC8790058</ArticleId><ArticleId IdType="pubmed">35095900</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts I., Wright Muelas M., Taylor J. M., Davison A. S., Xu Y., Grixti J. M., et al. (2022). Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome. Metabolomics 18, 6&#x2013;19. 10.1007/s11306-021-01859-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-021-01859-3</ArticleId><ArticleId IdType="pmc">PMC8686810</ArticleId><ArticleId IdType="pubmed">34928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Robertson J. L., Senger R. S., Talty J., Du P., Sayed-Issa A., Avellar M. L., et al. (2022). Alterations in the molecular composition of COVID-19 patient urine, detected using Raman spectroscopic/computational analysis. PLoS One 17, e0270914&#x2013;e0270916. 10.1371/journal.pone.0270914</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0270914</ArticleId><ArticleId IdType="pmc">PMC9292080</ArticleId><ArticleId IdType="pubmed">35849572</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothan H. A., Byrareddy S. N. (2020). Epidemiology and pathogenesis of coronavirus disease (COVID-19). Nov. Res. Microbiol. J. 4, 675&#x2013;687. 10.21608/nrmj.2020.84016</Citation><ArticleIdList><ArticleId IdType="doi">10.21608/nrmj.2020.84016</ArticleId><ArticleId IdType="pmc">PMC7127067</ArticleId><ArticleId IdType="pubmed">32113704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruffieux H., Hanson A. L., Lodge S., Lawler N. G., Whiley L., Gray N., et al. (2022). A patient-centric modeling framework captures recovery from SARS-CoV-2 infection. doi: 10.1038/s41590-022-01380-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01380-2</ArticleId><ArticleId IdType="pmc">PMC9892000</ArticleId><ArticleId IdType="pubmed">36717723</ArticleId></ArticleIdList></Reference><Reference><Citation>Saccon E., Bandera A., Scium&#xe8; M., Mikaeloff F., Lashari A. A., Aliberti S., et al. (2021). Distinct metabolic profile associated with a fatal outcome in COVID-19 patients during the early epidemic in Italy. Microbiol. Spectr. 9, e0054921&#x2013;e0054927. 10.1128/spectrum.00549-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00549-21</ArticleId><ArticleId IdType="pmc">PMC8565516</ArticleId><ArticleId IdType="pubmed">34468185</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheb Sharif-Askari N., Soares N. C., Mohamed H. A., Saheb Sharif-Askari F., Alsayed H. A. H., Al-Hroub H., et al. (2022). Saliva metabolomic profile of COVID-19 patients associates with disease severity. Metabolomics 18, 81. 10.1007/s11306-022-01936-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-022-01936-1</ArticleId><ArticleId IdType="pmc">PMC9589589</ArticleId><ArticleId IdType="pubmed">36271948</ArticleId></ArticleIdList></Reference><Reference><Citation>San Juan I., Bruzzone C., Bizkarguenaga M., Bernardo-Seisdedos G., La&#xed;n A., Gil-Redondo R., et al. (2020). Abnormal concentration of porphyrins in serum from COVID-19 patients. Br. J. Haematol. 190, e265&#x2013;e267. 10.1111/bjh.17060</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.17060</ArticleId><ArticleId IdType="pmc">PMC7436216</ArticleId><ArticleId IdType="pubmed">32745239</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmelter F., F&#xf6;h B., Mallagaray A., Rahm&#xf6;ller J., Ehlers M., Lehrian S., et al. (2021). Metabolic and lipidomic markers differentiate COVID-19 from non-hospitalized and other intensive care patients. Front. Mol. Biosci. 8, 737039. 10.3389/FMOLB.2021.737039</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/FMOLB.2021.737039</ArticleId><ArticleId IdType="pmc">PMC8686182</ArticleId><ArticleId IdType="pubmed">34938772</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuurman A. R., L&#xe9;opold V., Pereverzeva L., Chouchane O., Reijnders T. D. Y., Brabander J. de, et al. (2022). The platelet lipidome is altered in patients with COVID-19 and correlates with platelet reactivity. Thromb. Haemost. 122, 1683&#x2013;1692. 10.1055/s-0042-1749438</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1749438</ArticleId><ArticleId IdType="pmc">PMC9512584</ArticleId><ArticleId IdType="pubmed">35850149</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen B., Yi X., Sun Y., Bi X., Du J., Zhang C., et al. (2020). Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59&#x2013;72.e15. 10.1016/j.cell.2020.05.032</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId><ArticleId IdType="pmc">PMC7254001</ArticleId><ArticleId IdType="pubmed">32492406</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi D., Yan R., Lv L., Jiang H., Lu Y., Sheng J., et al. (2021). The serum metabolome of COVID-19 patients is distinctive and predictive. Metabolism 118, 154739. 10.1016/j.metabol.2021.154739</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154739</ArticleId><ArticleId IdType="pmc">PMC7920809</ArticleId><ArticleId IdType="pubmed">33662365</ArticleId></ArticleIdList></Reference><Reference><Citation>Sindelar M., Stancliffe E., Schwaiger-Haber M., Anbukumar D. S., Adkins-Travis K., Goss C. W., et al. (2021). Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity. Cell Rep. Med. 2, 100369. 10.1016/j.xcrm.2021.100369</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100369</ArticleId><ArticleId IdType="pmc">PMC8292035</ArticleId><ArticleId IdType="pubmed">34308390</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J. W., Lam S. M., Fan X., Cao W. J., Wang S. Y., Tian H., et al. (2020). Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. Cell Metab. 32, 188&#x2013;202.e5. 10.1016/j.cmet.2020.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7311890</ArticleId><ArticleId IdType="pubmed">32610096</ArticleId></ArticleIdList></Reference><Reference><Citation>Spick M., Campbell A., Baricevic-Jones I., von Gerichten J., Lewis H. M., Frampas C. F., et al. (2022a). Multi-omics reveals mechanisms of partial modulation of COVID-19 dysregulation by glucocorticoid treatment. Int. J. Mol. Sci. 23, 12079. 10.3390/ijms232012079</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232012079</ArticleId><ArticleId IdType="pmc">PMC9602480</ArticleId><ArticleId IdType="pubmed">36292938</ArticleId></ArticleIdList></Reference><Reference><Citation>Spick M., Lewis H. M., Frampas C. F., Longman K., Costa C., Stewart A., et al. (2022b). An integrated analysis and comparison of serum, saliva and sebum for COVID-19 metabolomics. Sci. Rep. 12, 11867&#x2013;11912. 10.1038/s41598-022-16123-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-16123-4</ArticleId><ArticleId IdType="pmc">PMC9278322</ArticleId><ArticleId IdType="pubmed">35831456</ArticleId></ArticleIdList></Reference><Reference><Citation>Spick M., Longman K., Frampas C., Lewis H., Costa C., Walters D. D., et al. (2021). Changes to the sebum lipidome upon COVID-19 infection observed via rapid sampling from the skin. EClinicalMedicine 33, 100786. 10.1016/j.eclinm.2021.100786</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.100786</ArticleId><ArticleId IdType="pmc">PMC7935689</ArticleId><ArticleId IdType="pubmed">33718846</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Chen D., Yuan D., Lausted C., Choi J., Dai C. L., et al. (2020). Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19. Cell 183, 1479&#x2013;1495.e20. 10.1016/J.CELL.2020.10.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.CELL.2020.10.037</ArticleId><ArticleId IdType="pmc">PMC7598382</ArticleId><ArticleId IdType="pubmed">33171100</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D. G., Ng R. H., Wang K., Choi J., et al. (2022). Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881&#x2013;895.e20. 10.1016/j.cell.2022.01.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak W., Huang N., B&#xe9;cavin C., Berg M., Queen R., Litvinukova M., et al. (2020). SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 26, 681&#x2013;687. 10.1038/s41591-020-0868-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas T., Stefanoni D., Reisz J. A., Nemkov T., Bertolone L., Francis R. O., et al. (2020). COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight 5, e140327. 10.1172/jci.insight.140327</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.140327</ArticleId><ArticleId IdType="pmc">PMC7453907</ArticleId><ArticleId IdType="pubmed">32559180</ArticleId></ArticleIdList></Reference><Reference><Citation>Torretta E., Garziano M., Poliseno M., Capitanio D., Biasin M., Santantonio T. A., et al. (2021). Severity of covid&#x2010;19 patients predicted by serum sphingolipids signature. Int. J. Mol. Sci. 22, 10198. 10.3390/ijms221910198</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910198</ArticleId><ArticleId IdType="pmc">PMC8508132</ArticleId><ArticleId IdType="pubmed">34638539</ArticleId></ArticleIdList></Reference><Reference><Citation>Vald&#xe9;s A., Moreno L. O., Rello S. R., Ordu&#xf1;a A., Bernardo D., Cifuentes A. (2022). Metabolomics study of COVID-19 patients in four different clinical stages. Sci. Rep. 12, 1650. 10.1038/S41598-022-05667-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41598-022-05667-0</ArticleId><ArticleId IdType="pmc">PMC8803913</ArticleId><ArticleId IdType="pubmed">35102215</ArticleId></ArticleIdList></Reference><Reference><Citation>Velavan T. P., Meyer C. G. (2020). The COVID-19 epidemic. Trop. Med. Int. Health 25, 278&#x2013;280. 10.1111/tmi.13383</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tmi.13383</ArticleId><ArticleId IdType="pmc">PMC7169770</ArticleId><ArticleId IdType="pubmed">32052514</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Li X., Ning W., Gong S., Yang F., Fang C., et al. (2021). Multi-omic profiling of plasma reveals molecular alterations in children with COVID-19. Theranostics 11, 8008&#x2013;8026. &#x2013;8026. 10.7150/THNO.61832</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/THNO.61832</ArticleId><ArticleId IdType="pmc">PMC8315065</ArticleId><ArticleId IdType="pubmed">34335977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward R. A., Aghaeepour N., Bhattacharyya R. P., Clish C. B., Gaudilli&#xe8;re B., Hacohen N., et al. (2021). Harnessing the potential of multiomics studies for precision medicine in infectious disease. Open Forum Infect. Dis. 8, ofab483&#x2013;12. 10.1093/ofid/ofab483</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab483</ArticleId><ArticleId IdType="pmc">PMC8598922</ArticleId><ArticleId IdType="pubmed">34805429</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu D., Shu T., Yang X., Song J. X., Zhang M., Yao C., et al. (2020). Plasma metabolomic and lipidomic alterations associated with COVID-19. Natl. Sci. Rev. 7, 1157&#x2013;1168. 10.1093/NSR/NWAA086</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/NSR/NWAA086</ArticleId><ArticleId IdType="pmc">PMC7197563</ArticleId><ArticleId IdType="pubmed">34676128</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Cyr A., Gruen D. S., Lovelace T. C., Benos P. V., Das J., et al. (2022). Lipidomic signatures align with inflammatory patterns and outcomes in critical illness. Nat. Commun. 13, 6789. 10.1038/s41467-022-34420-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-34420-4</ArticleId><ArticleId IdType="pmc">PMC9647252</ArticleId><ArticleId IdType="pubmed">36357394</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P., Chen D., Ding W., Wu P., Hou H., Bai Y., et al. (2021). The trans-omics landscape of COVID-19. Nat. Commun. 12, 4543&#x2013;4616. 10.1038/s41467-021-24482-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24482-1</ArticleId><ArticleId IdType="pmc">PMC8316550</ArticleId><ArticleId IdType="pubmed">34315889</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Xu E., Bowe B., Al-Aly Z. (2022). Long-term cardiovascular outcomes of COVID-19. Nat. Med. 28 (3 28), 583&#x2013;590. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Zhou M., Luo P., Yin Z., Wang S., Liao T., et al. (2021). Plasma metabolomic profiling of patients recovered from coronavirus disease 2019 (COVID-19) with pulmonary sequelae 3 Months after discharge. Clin. Infect. Dis. 73, 2228&#x2013;2239. 10.1093/CID/CIAB147</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/CID/CIAB147</ArticleId><ArticleId IdType="pmc">PMC7929060</ArticleId><ArticleId IdType="pubmed">33596592</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue M., Zhang T., Cheng Z. J., Guo B., Zeng Y., Lin R., et al. (2022). Effect of a functional phospholipid metabolome-protein association pathway on the mechanism of COVID-19 disease progression. Int. J. Biol. Sci. 18, 4618&#x2013;4628. 10.7150/ijbs.72450</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.72450</ArticleId><ArticleId IdType="pmc">PMC9305269</ArticleId><ArticleId IdType="pubmed">35874944</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z., Wu D., Lu S., Qiu Y., Hua Z., Tan F., et al. (2022). Plasma metabolome and cytokine profile reveal glycylproline modulating antibody fading in convalescent COVID-19 patients. Proc. Natl. Acad. Sci. U. S. A. 119, 21170891199&#x2013;e2117089211. 10.1073/pnas.2117089119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2117089119</ArticleId><ArticleId IdType="pmc">PMC9407385</ArticleId><ArticleId IdType="pubmed">35943976</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C. S., Zhang B., Li M., Wei X., Gong K., Li Z., et al. (2022). Identification of serum metabolites enhancing inflammatory responses in COVID-19. Sci. China Life Sci. 65, 1971&#x2013;1984. 10.1007/s11427-021-2099-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11427-021-2099-7</ArticleId><ArticleId IdType="pmc">PMC9068507</ArticleId><ArticleId IdType="pubmed">35508791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S., Luo P., Xu J., Yang L., Ma P., Tan X., et al. (2021). Plasma metabolomic profiles in recovered Covid-19 patients without previous underlying diseases 3 months after discharge. J. Inflamm. Res. 14, 4485&#x2013;4501. 10.2147/JIR.S325853</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S325853</ArticleId><ArticleId IdType="pmc">PMC8434912</ArticleId><ArticleId IdType="pubmed">34522117</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X. D. (2015). Precision medicine, personalized medicine, omics and big data: Concepts and relationships. J. Pharmacogenomics Pharmacoproteomics 06, 1&#x2013;2. 10.4172/2153-0645.1000e144</Citation><ArticleIdList><ArticleId IdType="doi">10.4172/2153-0645.1000e144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Shang Y., Ren Y., Bie Y., Qiu Y., Yuan Y., et al. (2020). Omics study reveals abnormal alterations of breastmilk proteins and metabolites in puerperant women with COVID-19. Signal Transduct. Target Ther. 5, 247. 10.1038/s41392-020-00362-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00362-w</ArticleId><ArticleId IdType="pmc">PMC7581689</ArticleId><ArticleId IdType="pubmed">33097684</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>